Literature DB >> 21686837

The association of HTLV-1 infection, persistent intestinal infection with Strongyloides stercoralis and gastrointestinal lymphoma.

Mehul Choksi1, A J Joseph, Ebby Simon, Apurva Shah, Jeyamani Ramachandran, Balakrishnan S Ramakrishna.   

Abstract

Human T cell lymphotropic virus type 1 (HTLV-1) infection is a risk factor for Strongyloides stercoralis infection. HTLV-1 also predisposes to the development of T cell malignancies. We report a case of a patient with severe, treatment resistant Strongyloides infection and HTLV-1 infection who progressed to develop an advanced high grade T cell lymphoma of the intestine.

Entities:  

Year:  2009        PMID： 21686837      PMCID： PMC3027753          DOI： 10.1136/bcr.07.2008.0373

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  9 in total

1.  Human T-lymphotropic virus 1 adult T-cell lymphoma with Giardia and Strongyloides parasitism.

Authors:  P A Isotalo; B Toye; L Eidus
Journal:  Arch Pathol Lab Med       Date:  2000-08       Impact factor: 5.534

2.  A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1.

Authors:  Philippe R S Lagacé-Wiens; Godfrey K M Harding
Journal:  CMAJ       Date:  2007-08-28       Impact factor: 8.262

3.  A pilot study of HTLV-I infection in high-risk individuals & their family members from India.

Authors:  S Ramalingam; R Kannangai; K J Prakash; K Ajithkumar; M Jacob; R George; S Pradeepkumar; D Daniel; D Dennison; P G Babu
Journal:  Indian J Med Res       Date:  2001-06       Impact factor: 2.375

4.  Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).

Authors:  P Agapé; M C Copin; M Cavrois; G Panelatti; Y Plumelle; M Ossondo-Landeau; D Quist; N Grossat; B Gosselin; P Fenaux; E Wattel
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-04-01

5.  High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.

Authors:  A S Gabet; F Mortreux; A Talarmin; Y Plumelle; I Leclercq; A Leroy; A Gessain; E Clity; M Joubert; E Wattel
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

6.  Case report: adult T-cell leukemia/lymphoma associated with recurrent strongyloides hyperinfection.

Authors:  K R Phelps; S S Ginsberg; A W Cunningham; E Tschachler; H Dosik
Journal:  Am J Med Sci       Date:  1991-10       Impact factor: 2.378

7.  T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases.

Authors:  M S Pombo de Oliveira; E Matutes; T Schulz; S M Carvalho; H Noronha; J D Reaves; P Loureiro; C Machado; D Catovsky
Journal:  Int J Cancer       Date:  1995-03-16       Impact factor: 7.396

Review 8.  An HTLV-I vaccine: why, how, for whom?

Authors:  G de Thé; R Bomford
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

9.  Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia.

Authors:  Lee Ratner; Christian Grant; Bevin Zimmerman; Joseph Fritz; Gary Weil; Alex Denes; Rama Suresh; Nancy Campbell; Steve Jacobson; Michael Lairmore
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047
  9 in total
  3 in total

1.  Strongyloides Superinfection After Liver Transplantion.

Authors:  Andrew Ofosu; John Higgins; Joseph S Frye; Radhika Kumari; Monique T Barakat
Journal:  Dig Dis Sci       Date:  2020-11-21       Impact factor: 3.199

2.  Synchronous MALT lymphoma of the colon and stomach and regression after eradication of Strongyloides stercoralis and Helicobacter pylori.

Authors:  Kevin Singh; Soren Gandhi; Behzad Doratotaj
Journal:  BMJ Case Rep       Date:  2018-07-03

Review 3.  Clinico-epidemiological spectrum of strongyloidiasis in India: Review of 166 cases.

Authors:  Manisha Paul; Suneeta Meena; Pratima Gupta; Sweta Jha; U Sasi Rekha; V Pradeep Kumar
Journal:  J Family Med Prim Care       Date:  2020-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.